X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Drug Discovery Outsourcing Companies

This report lists the top Global Drug Discovery Outsourcing companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Drug Discovery Outsourcing industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Global Drug Discovery Outsourcing Top Companies

  1. Genscript

  2. Dalton Pharma Services

  3. Evotec

  4. Curia

  5. Charles River

*Disclaimer: Top companies sorted in no particular order

Global Drug Discovery Outsourcing Market Major Players

Global Drug Discovery Outsourcing Market Concentration

Global Drug Discovery Outsourcing  Market Concentration

Global Drug Discovery Outsourcing Company List

                              • Charles River Laboratories International, Inc.

                              • GenScript Biotech Corporation

                              • Curia Inc.

                              • Dalton Pharma Services

                              • Evotec SE

                              • Thermo Fisher Scientific (PPD, Inc.)

                              • Oncodesign

                              • Jubilant Life Sciences Limited

                              • Eurofins Scientific

                              • WuXi AppTec

                              • Laboratory Corporation of America Holdings


                          Specific to Global Drug Discovery Outsourcing Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Drug Discovery Outsourcing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)